Systemic sclerosis Mimics

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000076" target="_blank" >RIV/00023728:_____/19:N0000076 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/systemic-sclerosis-mimics" target="_blank" >https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/systemic-sclerosis-mimics</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5772/intechopen.88546" target="_blank" >10.5772/intechopen.88546</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Systemic sclerosis Mimics

Popis výsledku v původním jazyce

Many clinical conditions are presenting with sclerosis of the skin and with tissue fibrosis. These conditions may be confused with systemic sclerosis (SSc, scleroderma). These diseases and disabilities are generally referred to as systemic sclerosis mimics or scleroderma-like syndromes. These disorders have very different etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow distinguishing these conditions from systemic sclerosis and from each other. A histopathological examination with clinicopathological correlation for diagnosis is important to spare the patients from ineffective treatments and inadequate management. In this chapter, we discussed localized scleroderma, lichen sclerosus, nephrogenic systemic fibrosis, eosinophilic fasciitis, scleromyxedema, and scleredema. These are often detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists, or preferably in collaboration with a dermatologist, must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.

Název v anglickém jazyce

Systemic sclerosis Mimics

Popis výsledku anglicky

Many clinical conditions are presenting with sclerosis of the skin and with tissue fibrosis. These conditions may be confused with systemic sclerosis (SSc, scleroderma). These diseases and disabilities are generally referred to as systemic sclerosis mimics or scleroderma-like syndromes. These disorders have very different etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow distinguishing these conditions from systemic sclerosis and from each other. A histopathological examination with clinicopathological correlation for diagnosis is important to spare the patients from ineffective treatments and inadequate management. In this chapter, we discussed localized scleroderma, lichen sclerosus, nephrogenic systemic fibrosis, eosinophilic fasciitis, scleromyxedema, and scleredema. These are often detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists, or preferably in collaboration with a dermatologist, must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

30226 - Rheumatology

Projekt

<a href="/cs/project/NV18-01-00161" target="_blank" >NV18-01-00161: Ateroskleróza a kardiovaskulární riziko u vybraných revmatických onemocnění</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

New Insight into Systemic Sclerosis

ISBN

978-3-030-02253-2

Počet stran výsledku

28

Strana od-do

87-114

Počet stran knihy

148

Název nakladatele

IntechOpen

Místo vydání

London

Kód UT WoS kapitoly

—